Ketoprofen topical - Celtic Pharma

Drug Profile

Ketoprofen topical - Celtic Pharma

Alternative Names: TDT-070

Latest Information Update: 20 Aug 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator IDEA
  • Developer Celtic Pharma
  • Class Analgesics; Anti-inflammatories
  • Mechanism of Action Cyclooxygenase inhibitors; Lipoxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Photodamage; Skin disorders

Most Recent Events

  • 20 Jun 2008 Clinical development is ongoing
  • 23 Feb 2006 IDEA 070 has been licensed to Celtic Pharma worldwide
  • 18 Mar 2005 Data presented at the 63rd Annual Meeting of the American Academy of Dermatology (AAD-2005) have been added to the adverse events and Skin disorders therapeutic trials sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top